Company: RGBP
Filing Date: 2025-12-05
Form Type: 253G1
Source: 0001493152-25-026350
Chunk: 2

Company: Regen BioPharma Inc
Filing Date: 2025-12-05
Form: 253G1
Chunk 2
---
ITIES OR DETERMINED IF THIS OFFERING CIRCULAR IS TRUTHFUL OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

GENERALLY, NO SALE MAY BE MADE TO YOU IN THIS OFFERING IF THE AGGREGATE PURCHASE PRICE YOU PAY IS MORE THAN 10% OF THE GREATER OF YOUR ANNUAL INCOME OR NET WORTH. DIFFERENT RULES APPLY TO ACCREDITED INVESTORS AND NON-NATURAL PERSONS. BEFORE MAKING ANY REPRESENTATION THAT YOUR INVESTMENT DOES NOT EXCEED APPLICABLE THRESHOLDS, WE ENCOURAGE YOU TO REVIEW RULE 251(d)(2)(i)(C) OF REGULATION A. FOR GENERAL INFORMATION ON INVESTING, WE ENCOURAGE YOU TO REFER TO www.investor.gov.

|         |     | Price     
 to Public |           |     | Underwriting     
 Discount         
 and Commissions1 |   |     | Proceeds  
 to Issuer |           |
|:--------|:----|:----------|----------:|:----|:-----------------|--:|:----|:----------|----------:|
| Per     
 Share   |     | $         |      0.01 |     |                  | 0 |     | $         |      0.01 |
| Total   
 Minimum |     | $         |         0 |     |                  | 0 |     | $         |         0 |
| Total   
 Maximum |     | $         | 1,000,000 |     |                  | 0 |     | $         | 1,000,000 |

<div align='center'>The date of this Offering Circular is December 5, 2025.</div>

THIS OFFERING CIRCULAR FOLLOWS THE OFFERING CIRCULAR FORMAT DESCRIBED IN PART II OF SEC FORM 1-A.

<div align='center'>1</div>

Contents

| CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS                                      |     |   3 |
| SUMMARY                                                                                        |     |   4 |
| Selected Financial Data                                                                        |     |   5 |
| DILUTION                                                                                       |     |   7 |
| ABOUT THE OFFERING                                                                             |     |  14 |
| USE OF PROCEEDS                                                                                |     |  16 |
| DISQUALIFYING EVENTS AND BAD ACTOR DISCLOSURE                                                  |     |  17 |
| MARK